Share Price of Care Ratings Hits 52-Week High as Earnings Surge in Q2FY25

Introduction

Care Ratings Limited, one of India’s leading credit rating agencies, recently announced its earnings for the second quarter and half-year ended September 30, 2024. The company’s stock surged to a 52-week high, reflecting the strong performance across both its standalone and consolidated financials.

Strong Earnings Drive Stock Surge

The robust financial performance in Q2FY25 resulted in Care Ratings stock hitting a new 52-week high. The company’s continued growth in the ratings and non-ratings businesses played a crucial role in this achievement. The share price movement mirrors investor confidence in the company’s future growth trajectory.

Consolidated Financial Highlights

For H1FY25, Care Ratings reported 21% YoY growth in consolidated revenue from operations, amounting to ₹196.29 crore. EBITDA for the same period grew by 30% YoY to ₹77.54 crore, with EBITDA margins at 40%. The company’s profit after tax (PAT) stood at ₹68.26 crore, representing 26% YoY growth, with a PAT margin of 31%.

In Q2FY25 alone, consolidated revenue from operations increased by 22% YoY to ₹117.37 crore. EBITDA and PAT for Q2FY25 rose by 33% and 31% YoY respectively, showcasing strong operational efficiency and profitability.

Standalone Financial Highlights

On a standalone basis, Care Ratings posted 18% YoY growth in revenue for H1FY25, totaling Rs 166.85 crore. EBITDA grew by 21% YoY to Rs 79.09 crore, maintaining a healthy EBITDA margin of 47%. PAT for the period was recorded at Rs 73.65 crore, an 18% YoY increase, with a PAT margin of 38%.

For Q2FY25, standalone revenue grew by 19% YoY to Rs 101.51 crore. Standalone EBITDA increased by 26% YoY to Rs 56.92 crore, while PAT grew by 22% YoY to Rs 49.64 crore.

Key Business Drivers

1. Ratings Business: The ratings business witnessed 19% YoY growth, contributing significantly to the company’s overall revenue. Care Ratings continues to hold a dominant position in the ratings industry, with strong momentum in rating capital market instruments and bank debt.
2. Non-Ratings Business: The non-ratings business also displayed impressive growth, expanding by 37% YoY. This diversification has helped the company improve its revenue mix, with non-ratings revenue now contributing 9.5% of total revenue.

Conclusion

Care Ratings’ strong financial performance in Q2 and H1FY25 has cemented its position as a key player in the credit rating space. The company’s share price, hitting a 52-week high, reflects the confidence investors have in its growth potential. As the company continues to expand its ratings and non-ratings businesses, it is well-positioned for future success.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. It is based on several secondary sources on the internet and is subject to changes. Please consult an expert before making related decisions.